| UniProt ID | UBE2F_HUMAN | |
|---|---|---|
| UniProt AC | Q969M7 | |
| Protein Name | NEDD8-conjugating enzyme UBE2F | |
| Gene Name | UBE2F | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 185 | |
| Subcellular Localization | ||
| Protein Description | Accepts the ubiquitin-like protein NEDD8 from the UBA3-NAE1 E1 complex and catalyzes its covalent attachment to other proteins. The specific interaction with the E3 ubiquitin ligase RBX2, but not RBX1, suggests that the RBX2-UBE2F complex neddylates specific target proteins, such as CUL5.. | |
| Protein Sequence | MLTLASKLKRDDGLKGSRTAATASDSTRRVSVRDKLLVKEVAELEANLPCTCKVHFPDPNKLHCFQLTVTPDEGYYQGGKFQFETEVPDAYNMVPPKVKCLTKIWHPNITETGEICLSLLREHSIDGTGWAPTRTLKDVVWGLNSLFTDLLNFDDPLNIEAAEHHLRDKEDFRNKVDDYIKRYAR | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 1 | Acetylation | -------MLTLASKL -------CCCHHHHC | 6.10 | 23201271 | |
| 7 | Acetylation | -MLTLASKLKRDDGL -CCCHHHHCCCCCCC | 53.04 | 19608861 | |
| 7 (in isoform 3) | Ubiquitination | - | 53.04 | - | |
| 7 | Ubiquitination | -MLTLASKLKRDDGL -CCCHHHHCCCCCCC | 53.04 | 23000965 | |
| 9 (in isoform 2) | Ubiquitination | - | 58.48 | - | |
| 9 | Ubiquitination | LTLASKLKRDDGLKG CCHHHHCCCCCCCCC | 58.48 | 23000965 | |
| 15 | Ubiquitination | LKRDDGLKGSRTAAT CCCCCCCCCCCEECC | 61.44 | 33845483 | |
| 26 | Phosphorylation | TAATASDSTRRVSVR EECCCCCCCCCCCHH | 22.71 | 27535140 | |
| 27 | Phosphorylation | AATASDSTRRVSVRD ECCCCCCCCCCCHHH | 27.73 | 23882029 | |
| 31 | Phosphorylation | SDSTRRVSVRDKLLV CCCCCCCCHHHHHHH | 15.04 | 23882029 | |
| 53 | Ubiquitination | ANLPCTCKVHFPDPN CCCCCEEEEECCCCC | 22.16 | 33845483 | |
| 65 | Ubiquitination | DPNKLHCFQLTVTPD CCCCEEEEEEEECCC | 4.67 | 33845483 | |
| 71 | Ubiquitination | CFQLTVTPDEGYYQG EEEEEECCCCCCCCC | 33.06 | 33845483 | |
| 73 | Ubiquitination | QLTVTPDEGYYQGGK EEEECCCCCCCCCCE | 50.74 | 33845483 | |
| 79 | Ubiquitination | DEGYYQGGKFQFETE CCCCCCCCEEEEEEE | 16.45 | 33845483 | |
| 85 | Phosphorylation | GGKFQFETEVPDAYN CCEEEEEEECCCHHH | 43.50 | 24719451 | |
| 97 | Ubiquitination | AYNMVPPKVKCLTKI HHHCCCCCCEEEECC | 48.53 | 33845483 | |
| 103 | Ubiquitination | PKVKCLTKIWHPNIT CCCEEEECCCCCCCC | 30.74 | 33845483 | |
| 124 | Phosphorylation | LSLLREHSIDGTGWA HHHHHHCCCCCCCCC | 20.02 | 20873877 | |
| 179 | Phosphorylation | FRNKVDDYIKRYAR- HHHHHHHHHHHHCC- | 12.13 | 21253578 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of UBE2F_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference |
|---|---|---|---|---|
| 1 | M | Acetylation |
| 23201271 |
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of UBE2F_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| RNF34_HUMAN | RNF34 | physical | 19549727 | |
| CUL5_HUMAN | CUL5 | physical | 22190037 | |
| VIF_HV1B1 | vif | physical | 22190037 | |
| VIF_HV1BR | vif | physical | 22190037 | |
| VIF_HV1H2 | vif | physical | 22190037 | |
| CUL5_HUMAN | CUL5 | physical | 23300442 | |
| RBX2_HUMAN | RNF7 | physical | 23300442 | |
| DCNL1_HUMAN | DCUN1D1 | physical | 23201271 | |
| DCNL2_HUMAN | DCUN1D2 | physical | 23201271 | |
| DCNL3_HUMAN | DCUN1D3 | physical | 23201271 | |
| CUL1_HUMAN | CUL1 | physical | 19942853 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1 AND LYS-7, AND MASSSPECTROMETRY. | |